- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 614081, 8 pages
Alkaline Phosphatase: The Next Independent Predictor of the Poor 90-Day Outcome in Alcoholic Hepatitis
Department of Gastroenterology with Endoscopy Unit, Medical University of Lublin, 8 Jaczewski Street, 20-954 Lublin, Poland
Received 14 April 2013; Revised 30 July 2013; Accepted 13 August 2013
Academic Editor: Atsushi Sakuraba
Copyright © 2013 Beata Kasztelan-Szczerbinska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- World Health Organisation, Global Status Raport on Alcohol and Health 2011, World Health Organisation, Geneva, Switzerland, 2011.
- A. J. McCullough, R. S. O'Shea, and S. Dasarathy, “Diagnosis and management of alcoholic liver disease,” Journal of Digestive Diseases, vol. 12, no. 4, pp. 257–262, 2011.
- R. S. O'Shea, S. Dasarathy, and A. J. McCullough, “Alcoholic liver disease,” Hepatology, vol. 51, no. 1, pp. 307–328, 2010.
- M. Amini and B. A. Runyon, “Alcoholic hepatitis 2010: a clinician's guide to diagnosis and therapy,” World Journal of Gastroenterology, vol. 16, no. 39, pp. 4905–4912, 2010.
- E. H. Forrest, C. D. J. Evans, S. Stewart et al., “Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score,” Gut, vol. 54, no. 8, pp. 1174–1179, 2005.
- W. Dunn, L. H. Jamil, L. S. Brown et al., “MELD accurately predicts mortality in patients with alcoholic hepatitis,” Hepatology, vol. 41, no. 2, pp. 353–358, 2005.
- E. H. Forrest, A. J. Morris, S. Stewart et al., “The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids,” Gut, vol. 56, no. 12, pp. 1743–1746, 2007.
- W. Srikureja, N. L. Kyulo, B. A. Runyon, and K. Q. Hu, “MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis,” Journal of Hepatology, vol. 42, no. 5, pp. 700–706, 2005.
- B. E. Vaa, S. K. Asrani, W. Dunn, P. S. Kamath, and V. H. Shah, “Influence of serum sodium on MELD-based survival prediction in alcoholic hepatitis,” Mayo Clinic Proceedings, vol. 86, no. 1, pp. 37–42, 2011.
- M. Dominguez, D. Rincón, J. G. Abraldes et al., “A new scoring system for prognostic stratification of patients with alcoholic hepatitis,” American Journal of Gastroenterology, vol. 103, no. 11, pp. 2747–2756, 2008.
- T. F. Babor, J. C. Higgins-Biddle, J. B. Saunders, and M. G. Monteiro, AUDIT the Alcohol Use Disorders: Identification Test Guidelines for Use in Primary Care, World Health Organisation, Geneva, Switzerland, 2nd edition, 2001.
- G. Basra, S. Basra, and S. Parupudi, “Symptoms and signs of acute alcoholic hepatitis,” World Journal of Hepatology, vol. 3, no. 5, pp. 118–120, 2011.
- R. Hamid and E. H. Forrest, “Is histology required for the diagnosis of alcoholic hepatitis: a review of published randomized controlled trials,” Gut, vol. 60, article A233, 2011.
- European Association for the Study of the Liver, “EASL Clinical Practice Guidelines: management of cholestatic liver diseases,” Journal of Hepatology, vol. 51, no. 2, pp. 237–267, 2009.
- H. H. Tan, S. Virmani, and P. Martin, “Controversies in the management of alcoholic liver disease,” Mount Sinai Journal of Medicine, vol. 76, no. 5, pp. 484–498, 2009.
- J. Altamirano, C. Fagundes, M. Dominguez et al., “Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis,” Clinical Gastroenterology and Hepatology, vol. 10, no. 1, pp. 65–71, 2012.
- J. P. Cervoni, T. Thévenot, D. Weil et al., “C-reactive protein predicts short-term mortality in patients with cirrhosis,” Journal of Hepatology, vol. 56, no. 6, pp. 1299–1304, 2012.
- H. Garg, A. Kumar, V. Garg, P. Sharma, B. C. Sharma, and S. K. Sarin, “Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure,” Digestive and Liver Disease, vol. 44, no. 2, pp. 166–171, 2012.
- G. V. Papatheodoridis, E. Cholongitas, E. Dimitriadou, G. Touloumi, V. Sevastianos, and A. J. Archimandritis, “MELD versus Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis,” World Journal of Gastroenterology, vol. 11, no. 20, pp. 3099–3104, 2005.
- M. O. Martinez, H. Sayles, R. Vivekanandan, S. D'Souza, and M. C. Florescu, “Hepatorenal syndrome: are we missing some prognostic factors?” Digestive Diseases and Sciences, vol. 57, no. 1, pp. 210–214, 2012.
- T. I. Huo, J. C. Wu, H. C. Lin et al., “Evaluation of the increase in model for end-stage liver disease (ΔMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score,” Journal of Hepatology, vol. 42, no. 6, pp. 826–832, 2005.
- L. Spahr, L. Rubbia-Brandt, M. Genevay, A. Hadengue, and E. Giostra, “Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitis,” BMC Gastroenterology, vol. 11, article 115, 2011.
- A. K. Singal, P. S. Kamath, G. J. Gores, and V. H. Shah, “Alcoholic hepatitis: current challenges and future directions,” Clinical Gastroenterology and Hepatology, 2013.
- R. Bettini and M. Gorini, “Effectiveness of ursodeoxycholic acid associated silymarin in the treatment of chronic athrylic hepatopathy,” Clinica Terapeutica, vol. 153, no. 5, pp. 305–307, 2002.
- G. Pelletier, D. Roulot, T. Davion et al., “A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice,” Hepatology, vol. 37, no. 4, pp. 887–892, 2003.
- F. Salerno, M. Merli, M. Cazzaniga et al., “MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt,” Journal of Hepatology, vol. 36, no. 4, pp. 494–500, 2002.
- R. Wiesner, E. Edwards, R. Freeman et al., “Model for end-stage liver disease (MELD) and allocation of donor livers,” Gastroenterology, vol. 124, no. 1, pp. 91–96, 2003.
- B. Angermayr, A. Luca, F. König et al., “Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score,” European Journal of Clinical Investigation, vol. 39, no. 1, pp. 65–71, 2009.
- K. A. Attia, K. C. Ackoundou-N'guessan, A. T. N'dri-yoman et al., “Child-Pugh-Turcott versus Meld score for predicting survival in a retrospective cohort of black African cirrhotic patients,” World Journal of Gastroenterology, vol. 14, no. 2, pp. 286–291, 2008.
- D. Gotthardt, K. H. Weiss, M. Baumgärtner et al., “Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation,” BMC Gastroenterology, vol. 9, article 72, 2009.
- X. H. Lv, H. B. Liu, Y. Wang, B. Y. Wang, M. Song, and M. J. Sun, “Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis,” Journal of Gastroenterology and Hepatology, vol. 24, no. 9, pp. 1547–1553, 2009.
- S. W. Biggins, H. J. Rodriguez, P. Bacchetti, N. M. Bass, J. P. Roberts, and N. A. Terrault, “Serum sodium predicts mortality in patients listed for liver transplantation,” Hepatology, vol. 41, no. 1, pp. 32–39, 2005.
- W. R. Kim, S. W. Biggins, W. K. Kremers et al., “Hyponatremia and mortality among patients on the liver-transplant waiting list,” New England Journal of Medicine, vol. 359, no. 10, pp. 1018–1026, 2008.
- N. Yamashiki, Y. Sugawara, S. Tamura et al., “Model for end-stage liver disease and model for end-stage liver disease-na scores predict both before-listing and wait-list mortality,” Transplantation Proceedings, vol. 44, no. 2, pp. 389–392, 2012.
- B. Angermayr, M. Cejna, F. Karnel et al., “Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt,” Gut, vol. 52, no. 6, pp. 879–885, 2003.
- T. D. Sandahl, P. Jepsen, P. Ott, and H. Vilstrup, “Validation of prognostic scores for clinical use in patients with alcoholic hepatitis,” Scandinavian Journal of Gastroenterology, vol. 46, no. 9, pp. 1127–1132, 2011.
- M. Sheth, M. Riggs, and T. Patel, “Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis,” BMC Gastroenterology, vol. 2, article 2, 2002.
- A. S. Soultati, S. P. Dourakis, A. Alexopoulou, M. Deutsch, L. Vasilieva, and A. J. Archimandritis, “Predicting utility of a model for end stage liver disease in alcoholic liver disease,” World Journal of Gastroenterology, vol. 12, no. 25, pp. 4020–4025, 2006.
- M. Somsouk, R. Kornfield, E. Vittinghoff, J. M. Inadomi, and S. W. Biggins, “Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk,” Liver Transplantation, vol. 17, no. 2, pp. 129–136, 2011.
- E. Akriviadis, R. Botla, W. Briggs, S. Han, T. Reynolds, and O. Shakil, “Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial,” Gastroenterology, vol. 119, no. 6, pp. 1637–1648, 2000.